Show simple item record

dc.contributor.authorWardley, Andrew M
dc.date.accessioned2009-04-02T16:01:12Z
dc.date.available2009-04-02T16:01:12Z
dc.date.issued2008-06
dc.identifier.citationThe need for advanced breast cancer treatment guidelines: results of an internet-based survey. 2008, 17 (3):275-81 Breasten
dc.identifier.issn0960-9776
dc.identifier.pmid18065223
dc.identifier.doi10.1016/j.breast.2007.10.014
dc.identifier.urihttp://hdl.handle.net/10541/59173
dc.description.abstractAlthough not curable, advanced breast cancer is treatable, however, treatment options are many and varied, and unlike early breast cancer (EBC), consistent guidelines are lacking. Breast cancer physicians were surveyed to assess the emotional impact of recurrence, factors affecting their treatment decisions, the role of guidelines in the management of advanced breast cancer and the need for new guidelines. Overall, distress levels were higher at recurrence than at first diagnosis of early breast cancer for both patients and physicians and the goal of treatment for this disease stage was to improve the patient's quality of life, delay disease progression and improve overall survival. While most respondents (96%) use the currently available guidelines, improvements are required, including the development of uniform global guidelines and recommendations for specific patient groups. Interactive computer programs and e-mail updates should also be utilised to ensure physicians are able to make fully informed decisions regarding optimum treatment.
dc.language.isoenen
dc.subjectBreast Canceren
dc.subjectClinical Guidelinesen
dc.subjectRecurrenceen
dc.subjectTreatment Optionsen
dc.subject.meshAdult
dc.subject.meshBreast Neoplasms
dc.subject.meshDecision Making
dc.subject.meshDisease Progression
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInternet
dc.subject.meshPractice Guidelines as Topic
dc.subject.meshQuality of Life
dc.titleThe need for advanced breast cancer treatment guidelines: results of an internet-based survey.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK. andrew.wardley@christie.nhs.uken
dc.identifier.journalBreasten
html.description.abstractAlthough not curable, advanced breast cancer is treatable, however, treatment options are many and varied, and unlike early breast cancer (EBC), consistent guidelines are lacking. Breast cancer physicians were surveyed to assess the emotional impact of recurrence, factors affecting their treatment decisions, the role of guidelines in the management of advanced breast cancer and the need for new guidelines. Overall, distress levels were higher at recurrence than at first diagnosis of early breast cancer for both patients and physicians and the goal of treatment for this disease stage was to improve the patient's quality of life, delay disease progression and improve overall survival. While most respondents (96%) use the currently available guidelines, improvements are required, including the development of uniform global guidelines and recommendations for specific patient groups. Interactive computer programs and e-mail updates should also be utilised to ensure physicians are able to make fully informed decisions regarding optimum treatment.


Files in this item

This item appears in the following Collection(s)

Show simple item record